ArticleJournal of the National Cancer Institute2026
The National Cancer Institute's Cancer Information Service: 50 years of service to the nation.
Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The National Cancer Institute's (NCI) Cancer Information Service (CIS) was founded in 1975 in accordance with a Congressional mandate requiring NCI to provide accurate, timely, and reliable cancer information to the American public as part of the National Cancer Act. For 50 years, the CIS has provided cancer patients, caregivers, healthcare professionals, and the public with high-quality information and resources on topics across the cancer control continuum, cancer clinical trials, and tobacco use cessation. Throughout its history, the CIS has adapted to changes in the health communication environment and evolving consumer needs, for example, by implementing additional access channels and launching a Spanish-language service to better serve the public. In addition to being a premier cancer information resource, the CIS is a unique laboratory for health communication research as data collected from the program is routinely used to monitor the public's emerging cancer information needs and to study information-seeking patterns across a variety of cancer control topics. This commentary aims to spotlight the role of the CIS as a federal health information resource that has been addressing the public's real-time cancer information needs and responding to national cancer research and public health priorities for over 5 decades.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.